巴楚医学2024，Vol.7Issue(4)：62-66,5.DOI:10.3969/j.issn.2096-6113.2024.04.007
常规超声联合S-Detect在BI-RADS 4类结节中的诊断价值
The Diagnostic Value of Conventional Ultrasound Combined with S-Detect in BI-RADS 4 Nodules
摘要
Abstract
Objective:To explore the diagnostic value of S-Detect technology in differentiating benign from malignant breast nodules of various sizes.Methods:A total of 412 patients(456 nodules)with Breast Imaging Reporting and Data System(BI-RADS)category 4 nodules who visited Yichang Central People's Hospital between October 2019 and October 2022 were collected.The pathological examination results were used as the gold standard.By comparing the receiver operating characteristic curve(ROC),sensitivity(SE),specificity(SP),accuracy(ACC),positive predictive value(PPV),and negative predictive value(NPV),the diagnostic value of conventional ultrasound,S-Detect,and conventional ultrasound combined with S-Detect for BI-RADS category 4 nodules was evaluated.Results:Of the 456 BI-RADS category 4 nodules,200 were confirmed malignant and 256 benign by pathology.Compared with conventional ultrasound and S-Detect alone,the diagnostic efficacy of conventional ultrasound combined with S-Detect was significantly improved(all P＜0.05).For BI-RADS category 4 nodules with a maximum diameter ≤20 mm,the SE,SP,ACC,PPV,NPV,and AUC of combined conventional ultrasound and S-Detect were 91.96％,95.12％,94.01％,91.15％,95.59％and 0.935,respectively.For BI-RADS category 4 nodules with a maximum diameter＞20 mm,the corresponding values were 98.86％,90.20％,96.40％,94.57％,97.87％and 0.945,respectively.Conclusion:Conventional ultrasound combined with S-Detect has a high diagnostic value in differentiating the benign and malignant of BI-RADS category 4 breast nodules of various sizes.关键词
S-Detect/常规超声/乳腺结节/BI-RADS 4类结节Key words
S-Detect/conventional ultrasound/breast nodules/BI-RADS category 4 nodules分类
医药卫生引用本文复制引用
邢博缘,付承辉,顾晨,陈红敏,杜志勇..常规超声联合S-Detect在BI-RADS 4类结节中的诊断价值[J].巴楚医学,2024,7(4):62-66,5.基金项目
湖北省教育厅科学研究项目(No:B2022030) （No:B2022030）
三峡大学国家中医药管理局中药药理科研三级实验室开放基金(No:2023PTCM09) （No:2023PTCM09）
